The estimated Net Worth of Bradley Langdale is at least 315 千$ dollars as of 6 May 2019. Mr. Langdale owns over 20,542 units of Conformis stock worth over 214,569$ and over the last 8 years he sold CFMS stock worth over 100,843$. In addition, he makes 0$ as Independent Director at Conformis.
Bradley has made over 4 trades of the Conformis stock since 2017, according to the Form 4 filled with the SEC. Most recently he sold 20,542 units of CFMS stock worth 59,161$ on 6 May 2019.
The largest trade he's ever made was exercising 80,000 units of Conformis stock on 26 April 2018 worth over 112,000$. On average, Bradley trades about 9,727 units every 57 days since 2016. As of 6 May 2019 he still owns at least 94,942 units of Conformis stock.
You can see the complete history of Mr. Langdale stock trades at the bottom of the page.
Bradley R. Langdale serves as Independent Director of the Company. Mr. Langdale served as a member of our board of directors since May 2008. From February 1996 until his retirement from active employment in December 2007, Mr. Langdale served in various roles at Masimo Corporation, a noninvasive monitoring technology company, including executive vice president, chief financial officer and executive vice president, chief marketing officer. From November 2015 until August 2018, Mr. Langdale served as a Director of Neurorecovery Technologies, Inc., a medical technology company focused on the design and development of devices and applications to help restore function and movement in patients with paralysis. In addition, Mr. Langdale previously served as director of finance for CareLine, Inc., an emergency medical services provider; manager of financial forecasting for Sunrise Company, a private real estate development company; and as a senior accountant for Price Waterhouse & Company LLP (now PricewaterhouseCoopers LLP), a global professional services organization. Mr. Langdale is a Certified Public Accountant and has a B.A. in Economics/Business from the University of California, Los Angeles.
Bradley Langdale is 55, he's been the Independent Director of Conformis since 2008. There are 6 older and 7 younger executives at Conformis. The oldest executive at Conformis Inc. is Kenneth Fallon, 80, who is the Independent Chairman of the Board.
Bradley's mailing address filed with the SEC is C/O CONFORMIS, INC., 600 TECHNOLOGY PARK DRIVE, BILLERICA, MA, 01821.
Over the last 9 years, insiders at Conformis have traded over 10,769,806$ worth of Conformis stock and bought 583,200 units worth 267,840$ . The most active insiders traders include Capital Management Llcchris...、Philipp Lang、Mark A Augusti. On average, Conformis executives and independent directors trade stock every 21 days with the average trade being worth of 122,083$. The most recent stock trade was executed by Mark A Augusti on 7 May 2022, trading 22,396 units of CFMS stock currently worth 10,302$.
our mission patients vary in more ways than gender, race, and size. at conformis, we believe that optimizing implant fit and performance requires a patient-specific approach. our mission is to provide best-in-class, patient-specific implants and instrumentation that offer unique advantages over traditional orthopedic implants. we start with a simple idea: make the implant fit the patient rather than forcing the patient to fit the implant. our implants are individually sized and shaped to fit to each patient’s unique anatomy, providing precise anatomic fit and preserving healthy tissue. our disposable, patient-specific cutting and placement guides also eliminate many of the tools required for traditional orthopedic surgery and simplify surgical technique. by combining our personalized implants with our unique instrumentation, a surgeon is able to provide a custom solution that preserves more of a patient’s joint and minimizes surgical trauma. our company conformis, inc. is a privately h
Conformis executives and other stock owners filed with the SEC include: